WebbReata Pharmaceuticals is registered under the ticker NASDAQ:RETA . Their stock opened with $11.00 in its May 26, 2016 IPO. Stock Symbol NASDAQ:RETA Money Raised at IPO $60.5M IPO Share Price $11.00 IPO Date May 26, 2016 Stock chart by Investors Number of Lead Investors 7 Number of Investors 9 Reata Pharmaceuticals is funded by 9 investors. WebbDirector at Reata Pharmaceuticals Location: United States James has served as a member of the Board of Directors of Reata Pharmaceuticals since July 2004. James is a member of the Board of Managers of Snowbird Holdings, LLC and Trinity Summits, LLC.
SouthEast Personnel Leasing - Peo Systems
Webb14 apr. 2024 · Reata Pharmaceuticals (NASDAQ:RETA – Get Rating) had its price target boosted by Stifel Nicolaus from $105.00 to $115.00 in a report issued on Thursday morning, The Fly reports.A number of other research firms have also commented on RETA. The Goldman Sachs Group lifted their price target on shares of Reata Pharmaceuticals … WebbReata Holdings is a mult-faceted insurance and financial services organization. We continue expanding with new technology a nd developing innovative and new products that solidify our role as a leader. We provide insurance solutions and asset management services for over 15,000 clients. chronic compartment syndrome calf treatment
John Ratliff - President-CEO - Reata Holdings, Inc.
WebbReata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. The Company concentrates on small-molecule therapeutics with mechanisms of action for the treatment of severe, life-threatening diseases. Its lead programs are omaveloxolone in a rare neurological … http://reataholdings.net/about-us/ Webb14 apr. 2024 · Book now at Reata in Fort Worth, TX. Explore menu, see photos and read 7223 reviews: "Chili chicken rellenos were excellent. Unfortunately the chicken fried staek was dry.". chronic condition health home iowa